Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022

Amit Hazan Maintained (BVS) at Hold with Decreased Target to $17 on, Mar 21st, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-17-on-mar-21st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Amit Hazan of Goldman Sachs, Maintained "Bioventus Inc." (BVS) at Hold with Decreased Target from $19 to $17 on, Mar 21st, 2022.

Amit has made no other calls on BVS in the last 4 months.



There are 2 other peers that have a rating on BVS. Out of the 2 peers that are also analyzing BVS, 0 agree with Amit's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Amit


  • Alexander Nowak of "Craig-Hallum" Initiated at Strong Buy and Held Target at $30 on, Tuesday, March 15th, 2022
  • Drew Ranieri of "Morgan Stanley" Maintained at Buy with Decreased Target to $18 on, Friday, March 11th, 2022